AI is changing
your health
Here's what it means for you.
Every week, the biggest AI breakthroughs in medicine — explained in plain English. What's real, what's hype, and what it could mean for your health. No medical degree required.
Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial
An off-the-shelf stem cell therapy for Parkinson's disease proved safe over 12 months, though the required immune-suppressing drugs carry notable risks.
Why people read Mednosis
We turn the firehose of medical-AI research into clear, trustworthy stories anyone can follow — clinicians included.
In plain English
Every breakthrough explained without the jargon — what it is, what they found, and why it could matter for your health.
No hype, just facts
We fact-check every summary against the original source and rate how close each finding really is to everyday care.
Depth on demand
Want the science? One tap reveals the clinical detail — study design, sample sizes, and limitations. Clinicians, this is for you.
Latest Research
When the real world becomes the trial
A turning point for gene editing in severe blood disorders
Health system learning enables generalist neuroimaging models
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
What Can Quantum Computing Do To Healthcare?
Anthropic found a hidden space where Claude puzzles over concepts
Get smarter about medical AI every week
Join clinicians and researchers staying ahead of the curve
Trending This Week
Research getting the most attention
Find What Matters to You
Filter research by how close it is to clinical practice
Browse by Specialty
Find research relevant to your field
Never Miss a
Breakthrough
Get curated AI in medicine research delivered weekly. No spam, unsubscribe anytime.
AI in Medicine 101
Learn how to read medical AI research, spot red flags in hype-y articles, and ask the right questions about new technologies.